Bayforest Capital’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.73K Sell
20
-19
-49% -$2.33K ﹤0.01% 879
2026
Q1
$4.59K Sell
39
-156
-80% -$21.8K 0.01% 830
2025
Q4
$32K Buy
+195
New +$30.5K 0.02% 646
2025
Q1
Sell
-488
Closed -$70.2K 870
2024
Q4
$70.2K Buy
+488
New +$70K 0.09% 397

Other funds holding RGEN

Bayforest Capital's RGEN Position: Q2 2026 in Review

Bayforest Capital reduced its Repligen (RGEN) stake by 49% in Q2 2026, selling an estimated $2.33K and leaving 20 shares worth $2.73K. The position accounts for ﹤0.01% of the portfolio, ranked #879.

Bayforest Capital first reported a position in RGEN in Q4 2024 and has held it in 4 quarters since. The position peaked at $70.2K in Q4 2024. 477 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Bayforest Capital held 20 shares of Repligen worth $2.73K as of Q2 2026.
  • Bayforest Capital sold 19 Repligen shares in Q2 2026, an estimated $2.33K.
  • Repligen made up ﹤0.01% of Bayforest Capital's portfolio in Q2 2026, its #879 holding.
  • Bayforest Capital first reported a position in Repligen in Q4 2024 and has held it in 4 quarters since.
  • Bayforest Capital's Repligen position peaked at $70.2K in Q4 2024.
  • 477 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.